In 2023, the World Health Assembly adopted a resolution to strengthen rehabilitation within health systems, calling for ...

Last 28 March 2025, the European Commission decided not to renew the conditional marketing authorisation for Translarna (ataluren) in Duchenne’s disease due to lack of efficacy after 11 years in the ...